Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Repligen Corporation, 3 years.
Repligen Corporation
Director
908 Devices Inc.
Director
BioLife Solutions Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | 908 Devices Inc. | Option exercise | +14,083 | — | — |
| Mar 2, 2026 | Repligen Corporation | Shares withheld for tax | −9,897 | $124.97 | $1,236,828 |
| Feb 24, 2026 | BioLife Solutions Inc. | Grant or award | +8,170 | — | — |
| Dec 4, 2025 | Repligen Corporation | Other | −2,000 | — | — |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −1,784 | $151.01 | $269,402 |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −2,100 | $152.17 | $319,557 |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −2,923 | $153.14 | $447,628 |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −2,500 | $154.32 | $385,800 |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −3,000 | $155.45 | $466,350 |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −5,737 | $156.22 | $896,234 |
| Nov 13, 2025 | Repligen Corporation | Open-market sale | −1,956 | $157.11 | $307,307 |
| Nov 13, 2025 | Repligen Corporation | Option exercise | +2,952 | $33.87 | $99,984 |
| Nov 12, 2025 | Repligen Corporation | Option exercise | +25,000 | $33.87 | $846,750 |
| Nov 12, 2025 | Repligen Corporation | Open-market sale | −3,741 | $154.92 | $579,556 |
| Nov 12, 2025 | Repligen Corporation | Open-market sale | −4,740 | $155.85 | $738,729 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.